Literature DB >> 9950563

Botox for the treatment of dynamic and hyperkinetic facial lines and furrows: adjunctive use in facial aesthetic surgery.

S Fagien1.   

Abstract

Our improved understanding of the pathophysiology of facial lines, wrinkles, and furrows has broadened the treatment options for a variety of facial cosmetic blemishes. The persistence or recurrence of certain facial rhytids after surgery has confirmed the lack of full comprehension of their origin. Glabellar forehead furrows (frown lines) and lateral canthal rhytids (crow's feet) have been the most popular facial lines that have been shown to be mostly the result of regional hyperkinetic muscles, and their eradication may be more suitable, at times, to chemodenervation than to soft-tissue fillers, skin resurfacing, or surgical resection. Aesthetic surgical procedures that have yielded suboptimal results may also occur from failure to recognize other causative factors including hyperkinetic or dynamic musculature, which may contribute to etiology of the visible soft-tissue changes and lack of persistent effect after surgery. Chemodenervation with botulinum toxin A (Botox) has proven to be useful both as a primary treatment for certain facial rhytids and as an adjunctive agent for a variety of facial aesthetic procedures to obtain optimal results.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9950563     DOI: 10.1097/00006534-199902000-00055

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  15 in total

1.  Balanced botox chemodenervation of the upper face: symmetry in motion.

Authors:  Jane J Olson
Journal:  Semin Plast Surg       Date:  2007-02       Impact factor: 2.314

2.  Neuromodulator threading: revisiting an approach to neurotoxin delivery.

Authors:  H William Higgins; Kachiu C Lee; Yoash Enzer
Journal:  J Clin Aesthet Dermatol       Date:  2014-06

3.  The effect of botulinum neurotoxin type A on capsule formation around silicone implants: the in vivo and in vitro study.

Authors:  Sang D Lee; Min-Hee Yi; Dong W Kim; Young Lee; YoungWoong Choi; Sang-Ha Oh
Journal:  Int Wound J       Date:  2014-03-07       Impact factor: 3.315

4.  Long term effects of intra-articular botulinum toxin A for refractory joint pain.

Authors:  M L Mahowald; J A Singh; D Dykstra
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

5.  [Treatment of crow's feet with two different botulinum toxin type A preparations in split-face technique].

Authors:  W Prager; E Wissmüller; B Kollhorst; A Böer; I Zschocke
Journal:  Hautarzt       Date:  2011-05       Impact factor: 0.751

6.  Usefulness of Gold Thread Implantation for Crow's Feet.

Authors:  Kee Cheol Shin; Tae Hui Bae; Woo Seob Kim; Han Koo Kim
Journal:  Arch Plast Surg       Date:  2012-01-15

7.  Newly Designed Quinolinol Inhibitors Mitigate the Effects of Botulinum Neurotoxin A in Enzymatic, Cell-Based, and ex Vivo Assays.

Authors:  Paul T Bremer; Michael Adler; Cecilia H Phung; Ajay K Singh; Kim D Janda
Journal:  J Med Chem       Date:  2017-01-03       Impact factor: 7.446

8.  Approach to eyebrow ptosis through the modified technique of Castanares.

Authors:  Pires Viana Giovanni; Pires Viana Giovanni Andre
Journal:  Indian J Plast Surg       Date:  2009 Jan-Jun

9.  Skin anti-aging strategies.

Authors:  Ruta Ganceviciene; Aikaterini I Liakou; Athanasios Theodoridis; Evgenia Makrantonaki; Christos C Zouboulis
Journal:  Dermatoendocrinol       Date:  2012-07-01

10.  Botulinum toxin type A for facial wrinkles.

Authors:  Cristina Pires Camargo; Jun Xia; Caroline S Costa; Rolf Gemperli; Maria Dc Tatini; Max K Bulsara; Rachel Riera
Journal:  Cochrane Database Syst Rev       Date:  2021-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.